Evidence map›Paper›PMID 34162366›Full record

ArticleMalaria journal2021

The Plasmodium falciparum Rh5 invasion protein complex reveals an excess of rare variant mutations.

Leonard Ndwiga, Victor Osoti, Kevin Omondi Ochwedo, Kevin Wamae, Philip Bejon, Julian C Rayner, George Githinji, Lynette Isabella Ochola-Oyier

Open access · goldAbstract read
In one paragraph

Article in Malaria journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. The N-terminal region of malaria vaccine candidatebioRxiv : the preprint server for biology · 2025
    Article
  6. Article
  7. Article
  8. Overview of the host immune response toJournal of parasitic diseases : official organ of the Indian Society for Parasitology · 2025
    Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. [Malarial antigens in the era of mRNA vaccines].Monatsschrift Kinderheilkunde : Organ der Deutschen Gesellschaft fur Kinderheilkunde · 2022
    Review
  18. Expanding the Malaria Antibody Toolkit: Development and Characterisation ofFrontiers in cellular and infection microbiology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Leonard NdwigaKEMRI-Wellcome Trust Research Programme, P.O. Box 230, Kilifi, 80108, Kenya.
Victor OsotiKEMRI-Wellcome Trust Research Programme, P.O. Box 230, Kilifi, 80108, Kenya.
Kevin Omondi OchwedoCentre for Biotechnology and Bioinformatics, University of Nairobi, Nairobi, Kenya.
Kevin WamaeKEMRI-Wellcome Trust Research Programme, P.O. Box 230, Kilifi, 80108, Kenya.
Philip BejonKEMRI-Wellcome Trust Research Programme, P.O. Box 230, Kilifi, 80108, Kenya.
Julian C RaynerCambridge Institute for Medical Research, University of Cambridge, Hills Road, Cambridge, CB2 0XY, UK.
George GithinjiKEMRI-Wellcome Trust Research Programme, P.O. Box 230, Kilifi, 80108, Kenya.
Lynette Isabella Ochola-OyierKEMRI-Wellcome Trust Research Programme, P.O. Box 230, Kilifi, 80108, Kenya. LiOchola@kemri-wellcome.org.ORCID http://orcid.org/0000-0003-4393-0470
Kenya Medical Research Institute · KEChurchill Hospital · GBUniversity of Cambridge · GBUniversity of Nairobi · KE

Funding

Wellcome TrustWellcome Trust 107568/Z/15/Z
6 · The paper itself

Abstract

backgroundThe invasion of the red blood cells by Plasmodium falciparum merozoites involves the interplay of several proteins that are also targets for vaccine development. The proteins PfRh5-PfRipr-PfCyRPA-Pfp113 assemble into a complex at the apical end of the merozoite and are together essential for erythrocyte invasion. They have also been shown to induce neutralizing antibodies and appear to be less polymorphic than other invasion-associated proteins, making them high priority blood-stage vaccine candidates. Using available whole genome sequencing data (WGS) and new capillary sequencing data (CS), this study describes the genetic polymorphism in the Rh5 complex in P. falciparum isolates obtained from Kilifi, Kenya.

methods162 samples collected in 2013 and 2014 were genotyped by capillary sequencing (CS) and re-analysed WGS from 68 culture-adapted P. falciparum samples obtained from a drug trial conducted from 2005 to 2007. The frequency of polymorphisms in the merozoite invasion proteins, PfRh5, PfRipr, PfCyRPA and PfP113 were examined and where possible polymorphisms co-occurring in the same isolates.

resultsFrom a total 70 variants, including 2 indels, 19 SNPs [27.1%] were identified by both CS and WGS, while an additional 15 [21.4%] and 36 [51.4%] SNPs were identified only by either CS or WGS, respectively. All the SNPs identified by CS were non-synonymous, whereas WGS identified 8 synonymous and 47 non-synonymous SNPs. CS identified indels in repeat regions in the p113 gene in codons 275 and 859 that were not identified in the WGS data. The minor allele frequencies of the SNPs ranged between 0.7 and 34.9% for WGS and 1.1-29.6% for CS. Collectively, 12 high frequency SNPs (> 5%) were identified: four in Rh5 codon 147, 148, 203 and 429, two in p113 at codons 7 and 267 and six in Ripr codons 190, 259, 524, 985, 1003 and 1039.

conclusionThis study reveals that the majority of the polymorphisms are rare variants and confirms a low level of genetic polymorphisms in all proteins within the Rh5 complex.

Indexed as

Multigene FamilyMutationPolymorphism, GeneticCarrier ProteinsPlasmodium falciparumProtozoan ProteinsCarrier ProteinsProtozoan ProteinsRH5 protein, Plasmodium falciparumCyRPALinkage disequilibriumMalariaP113Rh5RiprSingle nucleotide polymorphismsVaccine

Identifiers

PMID34162366
PMCPMC8220363
OpenAlexW3176956400

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.